Company News for Aug 4, 2022

• Shares of Moderna, Inc. MRNA surged 16% after it announced a $3 billion share buyback plan.

• Regeneron Pharmaceuticals, Inc.’s REGN shares rose 5.9% after it reported second-quarter 2022 earnings of $9.77 per share, beating the Zacks Consensus Estimate of $8.53 per share.

• Shares of Horizon Therapeutics Public Limited Company HZNP plummeted 18.5% after it reported second-quarter 2022 revenues of $876.4 million, missing the Zacks Consensus Estimate of $938.8 million.

• Exelon Corporation’s EXC shares fell 3.3% after it reported second-quarter 2022 earnings of $0.44 per share, missing the Zacks Consensus Estimate of $0.46 per share.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Regeneron Pharmaceuticals, Inc. (REGN) : Free Stock Analysis Report
 
Exelon Corporation (EXC) : Free Stock Analysis Report
 
Moderna, Inc. (MRNA) : Free Stock Analysis Report
 
Horizon Therapeutics Public Limited Company (HZNP) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research